IC
CPIX icon

Innealta Capital’s Cumberland Pharmaceuticals CPIX Stock Holding History

Innealta Capital’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-948
Closed -$1.45K – 488
2024
Q2 		$1.45K Buy
+948
New +$1.49K ﹤0.01% 1202

Other funds holding CPIX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Innealta Capital's CPIX Position: Q3 2024 in Review

Innealta Capital sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2024, closing a stake of 948 shares — an estimated $1.45K sold.

Innealta Capital first reported a position in CPIX in Q2 2024 and held it in 1 quarter. The position peaked at $1.45K in Q2 2024. 22 funds tracked by Wall St. Rank hold CPIX as of Q3 2024.

  • Innealta Capital reported no remaining Cumberland Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 948 Cumberland Pharmaceuticals shares in Q3 2024, an estimated $1.45K.
  • Innealta Capital first reported a position in Cumberland Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's Cumberland Pharmaceuticals position peaked at $1.45K in Q2 2024.
  • 22 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.